Wolverine Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-220
| Closed | -$10.6K | – | 1684 |
|
|
2025
Q3 | $9.92K | Sell |
220
-20,220
| -99% | -$944K | ﹤0.01% | 1368 |
|
|
2025
Q2 | $946K | Buy |
+20,440
| New | +$1M | 0.01% | 735 |
|
|
2024
Q3 | – | Sell |
-4,024
| Closed | -$189K | – | 1659 |
|
|
2024
Q2 | $167K | Buy |
+4,024
| New | +$180K | ﹤0.01% | 1021 |
|
|
2024
Q1 | – | Sell |
-32,788
| Closed | -$1.67M | – | 1686 |
|
|
2023
Q4 | $1.68M | Sell |
32,788
-15,941
| -33% | -$837K | 0.01% | 573 |
|
|
2023
Q3 | $2.83M | Buy |
48,729
+5,042
| +12% | +$309K | 0.03% | 456 |
|
|
2023
Q2 | $2.79M | Sell |
43,687
-10,265
| -19% | -$688K | 0.03% | 423 |
|
|
2023
Q1 | $3.74M | Buy |
53,952
+17,674
| +49% | +$1.25M | 0.04% | 387 |
|
|
2022
Q4 | $2.61M | Buy |
+36,278
| New | +$2.74M | 0.03% | 507 |
|
|
2019
Q2 | – | Sell |
-3,933
| Closed | -$187K | – | 1407 |
|
|
2019
Q1 | $187K | Sell |
3,933
-287,875
| -99% | -$14.3M | ﹤0.01% | 1037 |
|
|
2018
Q4 | $15.2M | Buy |
291,808
+74,430
| +34% | +$4M | 0.18% | 117 |
|
|
2018
Q3 | $13.5M | Buy |
217,378
+35,014
| +19% | +$2.08M | 0.16% | 132 |
|
|
2018
Q2 | $10.1M | Buy |
182,364
+129,681
| +246% | +$7M | 0.13% | 153 |
|
|
2018
Q1 | $3.33M | Buy |
+52,683
| New | +$3.39M | 0.04% | 362 |
|
|
2016
Q4 | – | Sell |
-2,404
| Closed | -$129K | – | 1179 |
|
|
2016
Q3 | $129K | Buy |
+2,404
| New | +$154K | ﹤0.01% | 938 |
|
|
2016
Q1 | – | Sell |
-11,204
| Closed | -$770K | – | 1242 |
|
|
2015
Q4 | $770K | Sell |
11,204
-6,650
| -37% | -$439K | 0.02% | 547 |
|
|
2015
Q3 | $1.06M | Buy |
17,854
+3,600
| +25% | +$228K | 0.02% | 489 |
|
|
2015
Q2 | $948K | Sell |
14,254
-5,600
| -28% | -$369K | 0.02% | 488 |
|
|
2015
Q1 | $1.28M | Buy |
19,854
+7,192
| +57% | +$450K | 0.03% | 390 |
|
|
2014
Q4 | $747K | Sell |
12,662
-2,122
| -14% | -$120K | 0.01% | 530 |
|
|
2014
Q3 | $756K | Buy |
14,784
+3,140
| +27% | +$157K | 0.02% | 552 |
|
|
2014
Q2 | $564K | Buy |
11,644
+6,144
| +112% | +$303K | 0.01% | 560 |
|
|
2014
Q1 | $285K | Buy |
+5,500
| New | +$293K | 0.01% | 758 |
|
|
2013
Q4 | – | Sell |
-37,900
| Closed | -$1.93M | – | 2704 |
|
|
2013
Q3 | $1.75M | Buy |
37,900
+10,000
| +36% | +$439K | 0.04% | 375 |
|
|
2013
Q2 | $1.25M | Buy |
+27,900
| New | +$1.21M | 0.03% | 413 |
|
Other funds holding BMY
VCM
VPM
Wolverine Asset Management's BMY Position: Q4 2025 in Review
Wolverine Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 220 shares — an estimated $10.6K sold.
Wolverine Asset Management first reported a position in BMY in Q2 2013 and held it in 24 quarters. The position peaked at $15.2M in Q4 2018. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Wolverine Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- Wolverine Asset Management sold 220 Bristol-Myers Squibb shares in Q4 2025, an estimated $10.6K.
- Wolverine Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 24 quarters.
- Wolverine Asset Management's Bristol-Myers Squibb position peaked at $15.2M in Q4 2018.
- 2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Wolverine Asset Management's 13F filing for Q4 2025, filed 2 Feb 2026.